Keyword: Ranbaxy Laboratories

News

India’s Sun Pharmaceutical to Buy Compatriot Ranbaxy

09.04.2014 - Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...

News

Fourth Ranbaxy Generics Plant Hit by FDA Ban

27.01.2014 - Indian drugmaker Ranbaxy Laboratories faces long delays and high costs in launching big-selling generic drugs in the U.S. after products from a fourth plant were banned due to...

News

Novartis Lifts Full-Year Outlook After Competition Delay

18.07.2013 - Novartis raised its full-year outlook on Wednesday after generic competition to its best-selling blood pressure pill was delayed, granting the Swiss drugmaker a temporary reprieve...

News

Ranbaxy CEO Omesh Sethi Quits

27.01.2011 - Ranbaxy Laboratories, India's top drugmaker, said on Thursday its chief financial officer had resigned, the third top official to quit after Japan's Daiichi Sankyo took majority...